Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05946655Completed
Randomised, open-label trial of ofloxacin and metronidazole in endometritis, sponsored by Jagiellonian University. Primary endpoint: Determination of the cut-off point of the number of plasma cells/1 HPF corresponding to histological CE at 3 months. Started Apr 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05946655.